Adding cetuximab to bevacizumab unhelpful in colorectal cancer

6 February 2009 Print this article Comments Share this article
Dutch oncologists have found that adding the EGFR inhibitor cetuximab to a combination of chemotherapy plus bevacizumab results in worse progression-free survival and lower quality of life in patients with metastatic colorectal cancer....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites